Loading...
Emerging therapies for severe asthma
Many patients with asthma have poorly controlled symptoms, and particularly for those with severe disease, there is a clear need for improved treatments. Two recent therapies licensed for use in asthma are omalizumab, a humanized monoclonal antibody that binds circulating IgE antibody, and bronchial...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3175451/ https://ncbi.nlm.nih.gov/pubmed/21896202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-9-102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|